- Home
- ATXS vs DXYZ Comparison
ATXS vs DXYZ Comparison
Compare ATXS & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- DXYZ
- Stock Information
- Founded
- ATXS 2008
- DXYZ N/A
- Country
- ATXS United States
- DXYZ
- Employees
- ATXS N/A
- DXYZ N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- DXYZ
- Sector
- ATXS Health Care
- DXYZ
- Exchange
- ATXS Nasdaq
- DXYZ Nasdaq
- Market Cap
- ATXS 401.2M
- DXYZ 413.3M
- IPO Year
- ATXS 2015
- DXYZ 2024
- Fundamental
- Price
- ATXS $6.65
- DXYZ $32.87
- Analyst Decision
- ATXS Strong Buy
- DXYZ
- Analyst Count
- ATXS 7
- DXYZ 0
- Target Price
- ATXS $32.43
- DXYZ N/A
- AVG Volume (30 Days)
- ATXS 304.1K
- DXYZ N/A
- Earning Date
- ATXS 08-11-2025
- DXYZ N/A
- Dividend Yield
- ATXS N/A
- DXYZ N/A
- EPS Growth
- ATXS N/A
- DXYZ N/A
- EPS
- ATXS N/A
- DXYZ N/A
- Revenue
- ATXS N/A
- DXYZ N/A
- Revenue This Year
- ATXS N/A
- DXYZ N/A
- Revenue Next Year
- ATXS N/A
- DXYZ N/A
- P/E Ratio
- ATXS N/A
- DXYZ N/A
- Revenue Growth
- ATXS N/A
- DXYZ N/A
- 52 Week Low
- ATXS $3.56
- DXYZ N/A
- 52 Week High
- ATXS $12.92
- DXYZ N/A
- Technical
- Relative Strength Index (RSI)
- ATXS 60.88
- DXYZ N/A
- Support Level
- ATXS $5.94
- DXYZ N/A
- Resistance Level
- ATXS $6.49
- DXYZ N/A
- Average True Range (ATR)
- ATXS 0.34
- DXYZ 0.00
- MACD
- ATXS -0.00
- DXYZ 0.00
- Stochastic Oscillator
- ATXS 74.74
- DXYZ 0.00
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About DXYZ Destiny Tech100 Inc. Common Stock
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.